The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-((S)-1-(((S)-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperidin-3-yl)-4-phenylimidazolidin-2-one ID: ALA5202684
PubChem CID: 138621575
Max Phase: Preclinical
Molecular Formula: C23H27N3O3
Molecular Weight: 393.49
Associated Items:
Names and Identifiers Canonical SMILES: O=C1NC(c2ccccc2)CN1[C@H]1CCCN(C[C@H]2COc3ccccc3O2)C1
Standard InChI: InChI=1S/C23H27N3O3/c27-23-24-20(17-7-2-1-3-8-17)15-26(23)18-9-6-12-25(13-18)14-19-16-28-21-10-4-5-11-22(21)29-19/h1-5,7-8,10-11,18-20H,6,9,12-16H2,(H,24,27)/t18-,19-,20?/m0/s1
Standard InChI Key: BDWMLCZMMGHSMH-NFBCFJMWSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-2.8876 1.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1730 1.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4585 1.2665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7442 1.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7442 2.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0297 2.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6847 2.5040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3991 2.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1136 2.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1136 1.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3991 1.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3991 0.4415 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7317 -0.0433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0528 0.2115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9867 -0.8279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8117 -0.8279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2966 -1.4954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9610 -2.2491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4460 -2.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2663 -2.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6020 -2.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1171 -1.4091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0666 -0.0433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6847 1.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4585 2.9165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1730 2.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8876 2.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6020 2.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6020 1.6790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 1
6 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
11 10 1 0
11 12 1 6
13 12 1 0
13 14 2 0
15 13 1 0
16 15 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
22 17 2 0
21 22 1 0
23 16 1 0
23 12 1 0
24 11 1 0
7 24 1 0
5 25 1 0
26 25 1 0
2 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 1 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.49Molecular Weight (Monoisotopic): 393.2052AlogP: 3.06#Rotatable Bonds: 4Polar Surface Area: 54.04Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.48CX Basic pKa: 7.63CX LogP: 2.78CX LogD: 2.35Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.87Np Likeness Score: -0.45
References 1. Wang S, Haikarainen A, Pohjakallio A, Sipilä J, Kaskinoro J, Juhila S, Jalava N, Koskinen M, Vesajoki M, Kumpulainen E, Pystynen J, Koskelainen T, Holm P, Din Belle D.. (2022) 2,3-Dihydrobenzo-dioxine piperidine derivatives as potent and selective α2c antagonists., 69 [PMID:35569686 ] [10.1016/j.bmcl.2022.128783 ]